"As the oldest and largest private teaching and specialty health care facility in Greater Cincinnati, TriHealth’s Good Samaritan Hospital is among the best hospitals in the region, providing a range of quality services to patients in Ohio, Indiana and Kentucky."

During the past decade, Good Samaritan Hospital - Cincinnati conducted 198 clinical trials. In the 10-year time frame, 198 clinical trials started and 99 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 68 clinical trials were completed. i.e. 86.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Good Samaritan Hospital - Cincinnati" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "TriHealth Inc." with 34 trials sponsored, "Alliance for Clinical Trials in Oncology" with 28 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 28 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Good Samaritan Hospital - Cincinnati" #1 collaborator was "National Cancer Institute (NCI)" with 115 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 7 trials as a collaborator and "Medical University of South Carolina" with 5 trials as a collaborator. Other collaborators include 104 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "Good Samaritan Hospital - Cincinnati" are "Recurrent Ovarian Carcinoma" (11 trials), "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Fallopian Tube Transitional Cell Carcinoma" (8 trials) and "Ovarian Seromucinous Carcinoma" (8 trials). Many other conditions were trialed in "Good Samaritan Hospital - Cincinnati" in a lesser frequency.

Most popular intervention types in "Good Samaritan Hospital - Cincinnati" are "Drug" (203 trials), "Other" (152 trials), "Biological" (98 trials), "Procedure" (74 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (64 trials), "Quality-of-Life Assessment" (60 trials), "Questionnaire Administration" (38 trials), "Computed Tomography" (35 trials) and "Carboplatin" (32 trials). Other intervention names were less common.

The vast majority of trials in "Good Samaritan Hospital - Cincinnati" are 224 trials for "All" genders, 90 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Good Samaritan Hospital - Cincinnati". undefined are not yet recruiting, 69 are recruiting, 111 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in Good Samaritan Hospital - Cincinnati, 2 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Good Samaritan Hospital - Cincinnati, 8 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 40 trials that are defined as “Not Applicable".